Back

Optimizing patient selection for cardiac resynchronization therapy in a multicenter study of Japanese patients: assessment of the MADIT-ICD benefit group

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Optimising the results of cardiac resynchronisation therapy Cardiac Resynchronisation Therapy (CRT) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Hiroyuki Sato

Tohoku University, Sendai (Japan)

5 More presentations in this session

Presentation thumbnail
Myocardial single photon emission computed tomography imaging to identify non-responders to cardiac resynchronization therapy in patients with non-left bundle branch block
Doctor T. Nakamura (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Assessment of mechanical dyssynchrony can improve the new ESC-2021 guidelines for cardiac resynchronization therapy
Professor L. Herbots (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Long-term efficacy of cardiac resynchronization therapy with triple-site ventricular stimulation in heart failure patients
Doctor M. Ogano (Shizuoka, JP)
Abstract Slides Video
Presentation thumbnail
A larger reduction of spatial mean QRS-T angle during cardiac resynchronisation therapy is associated with a lower risk of mortality and heart failure hospitalisation
Doctor S. Marinko (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Smaller intrinsic QRS area and smaller reduction of QRS area during cardiac resynchronisation therapy are associated with higher risk of ventricular arrhythmias and appropriate ICD therapy
Associate Professor R. Borgquist (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising the results of cardiac resynchronisation therapy

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The MADIT-ICD benefit risk score for Japanese patients -from Nippon Storm study-
thumbnail
Congress Presentation
Development and validation of the MADIT-ICD benefit risk score for Japanese patients - from Nippon Storm study
thumbnail
Congress Presentation
Prediction of CRT response using a novel CRT responder score in an Asian patient population

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources